Rusty Ray
CIK 1479159 · last filed 2018-01-08
Rusty Ray is a corporate insider who has filed 21 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing, for APRI, was dated Jan 8, 2018. Across all open-market trades the lifetime net is +$30.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.6K
2
21
$30.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SEELOS THERAPEUTICS, INC. (APRI) Delisted | Director | 565 | — | — | $30.7K | 19 | 2018-01-08 |
| NEXM | Director | 1,961 | $2.36 | $4.6K | $0 | 1 | 2010-04-01 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-08 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-06 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +11,250 | $0 | EDGAR |
| 2016-10-03 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +10,161 | $3.4K | EDGAR |
| 2016-07-01 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +8,605 | $3.4K | EDGAR |
| 2016-04-07 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | +5,927 | $3.4K | EDGAR |
| 2016-01-05 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-26 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-10-24 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Buy (P) | +3,500 | $5.2K | EDGAR |
| 2014-02-10 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-01-06 | SEELOS THERAPEUTICS, INC. (APRI) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.